Avenciguat (development name BI 685509) is a soluble guanylate cyclase activator developed by Boehringer Ingelheim for kidney disease, and cirrhosis.
References
Wikipedia
Avenciguat
Tags
- Carboxylic acids
- Disubstituted pyridines
- Drugs developed by Boehringer Ingelheim
- Ethoxy compounds
- Experimental drugs
- Pyrazoles
- Tetrahydroisoquinolines
- Tetrahydropyrans